{"disease":{"id":"fgf-receptor-gene-family-rearrangement","name":"fgf receptor gene family rearrangement"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06022289","title":"Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Tianjin Medical University Second Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}